We are live on ! Find out more
FBIO icon

Fortress Biotech
FBIO

77 hedge funds and large institutions have $117M invested in Fortress Biotech in 2020 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 30 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

114% more repeat investments, than reductions

Existing positions increased: 30 | Existing positions reduced: 14

92% more capital invested

Capital invested by funds: $60.6M → $117M (+$56M)

40% more first-time investments, than exits

New positions opened: 14 | Existing positions closed: 10

5% more funds holding

Funds holding: 73 → 77 (+4)

0.51% more ownership

Funds ownership: 1.83% → 2.33% (+0.51%)

Holders
77
Holders Change
+4
Holders Change %
+5.48%
% of All Funds
1.55%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
14
Increased
30
Reduced
14
Closed
10
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
NCM
Nantahala Capital Management
Connecticut
+$12.9M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$3.47M
3
Morgan Stanley
Morgan Stanley
New York
+$3.06M
4
BlackRock
BlackRock
New York
+$1.93M
5
Two Sigma Investments
Two Sigma Investments
New York
+$1.79M

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$1.95M
2
FIA
FNY Investment Advisers
New York
-$469K
3
Jane Street
Jane Street
New York
-$326K
4
Bank of America
Bank of America
North Carolina
-$86K
5
SG Americas Securities
SG Americas Securities
New York
-$85K
Name Holding Trade Value Shares
Change 		Change in
Stake
NCM
1
Nantahala Capital Management
Connecticut
$33.2M +$12.9M +253,333 +86%
BlackRock
2
BlackRock
New York
$18.4M +$1.93M +37,861 +14%
Vanguard Group
3
Vanguard Group
Pennsylvania
$13.2M +$3.47M +68,029 +45%
OM
4
Opaleye Management
Massachusetts
$10.3M – – –
State Street
5
State Street
Massachusetts
$4.7M +$910K +17,874 +30%
Morgan Stanley
6
Morgan Stanley
New York
$3.75M +$3.06M +60,074 +3,332%
Geode Capital Management
7
Geode Capital Management
Massachusetts
$3.58M +$451K +8,862 +18%
Two Sigma Investments
8
Two Sigma Investments
New York
$2.94M +$1.79M +35,122 +262%
Northern Trust
9
Northern Trust
Illinois
$2.87M +$27.9K +548 +1%
Acadian Asset Management
10
Acadian Asset Management
Massachusetts
$2.85M -$56.1K -1,102 -2%
CL
11
CPWM LLC
Washington
$2.04M +$340K +6,667 +25%
SAM
12
Shikiar Asset Management
New York
$1.84M +$373K +7,317 +32%
PAM
13
Panagora Asset Management
Massachusetts
$1.56M +$411K +8,079 +46%
N
14
Nuveen
North Carolina
$1.28M +$128K +2,513 +14%
Two Sigma Advisers
15
Two Sigma Advisers
New York
$916K +$587K +11,520 +321%
Bank of New York Mellon
16
Bank of New York Mellon
New York
$883K +$30.2K +593 +4%
6CM
17
683 Capital Management
New York
$808K – – –
Russell Investments Group
18
Russell Investments Group
United Kingdom
$796K +$671K +13,182 New
KAS
19
Kestra Advisory Services
Texas
$703K +$591K +11,601 New
Charles Schwab
20
Charles Schwab
California
$648K +$17K +334 +3%
Goldman Sachs
21
Goldman Sachs
New York
$626K +$526K +10,336 New
LPL Financial
22
LPL Financial
California
$615K +$517K +10,155 New
Jacobs Levy Equity Management
23
Jacobs Levy Equity Management
New Jersey
$557K -$9.07K -178 -2%
Wells Fargo
24
Wells Fargo
California
$541K +$128K +2,504 +39%
California Public Employees Retirement System
25
California Public Employees Retirement System
California
$527K +$43.8K +860 +11%
1
2 3 4

FBIO Hedge Fund Activity: Q3 2020 in Review

77 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q3 2020, worth a combined $117M — up 92% from $60.6M a quarter earlier.

Buyers outnumbered sellers: 14 funds opened new FBIO positions and 10 closed out — a net gain of 4 holders — while 30 added to existing stakes and 14 trimmed.

The largest buyer was Nantahala Capital Management, adding an estimated $12.9M. The largest seller was Renaissance Technologies, cutting an estimated $1.95M.

  • 77 institutional investors held Fortress Biotech (FBIO) as of Q3 2020, up from 73 in Q2 2020.
  • Funds reported $117M of Fortress Biotech stock for Q3 2020, up 92% quarter-over-quarter.
  • 14 funds opened new Fortress Biotech positions in Q3 2020 and 10 closed out, a net change of +4 holders.
  • The largest Fortress Biotech buyer in Q3 2020 was Nantahala Capital Management, an estimated $12.9M added.
  • The largest Fortress Biotech seller in Q3 2020 was Renaissance Technologies, an estimated $1.95M sold.

Based on aggregated 13F filings for Q3 2020.